NYSE American halts trading on Navidea stock after delisting recommended


The company has about two weeks to seek a review of the decision. It has received seven warning notices for delisting in the past five years.

Previous Lab Notes: Philadelphia gene therapy developer lands $10M; Marrazzo joins CHOP board
Next Family-run pharmacies struggle to survive in today's medical landscape